The Evaluation of Patients with Severe COVID-19 Pneumonia Who are Recieving Favipiravir Treatment

Introduction: There is no known specific treatment for Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Our retrospective study evaluates the effectiveness of steroid treatment and the factors affecting treatment in patients with severe Coronavirus disease-2019 (COVID-19) pneumonia that...

Descrición completa

Detalles Bibliográficos

Principais autores:	Servet ÖZTÜRK, Onur ÇOLAK, Semra KAVAS, Derya ÖZTÜRK ENGİN, Serap DİKTAŞ TAHTASAKAL, Dilek ERDOĞAN ARI, Öznur DEMİROLUK, Berna ÖZDEMİR, Büşra Meral ÇETİNKAYA, Merve KAÇAR EKER, İrem Asena DOĞAN, Haluk VAHABOĞLU, Canan AĞALAR
Formato:	Artigo
Idioma:	Inglês
Publicado:	Infectious Diseases and Clinical Microbiology Specialty Society of Turkey 2021-12-01
Series:	Mediterranean Journal of Infection, Microbes and Antimicrobials
Assuntos:	covid-19 sars-cov-2 favipiravir steroid
Acceso en liña:	http://mjima.org/abstract.php?id=238
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!